The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 27, 2012

Filed:

Apr. 23, 2010
Applicants:

Nolan James Dewdney, Saratoga, CA (US);

Ronald Charles Hawley, Glen Ridge, NJ (US);

Rama Kondru, Morris Plains, NJ (US);

Yingjie Lai, Cupertino, CA (US);

Yan Lou, Clifton, NJ (US);

Inventors:

Nolan James Dewdney, Saratoga, CA (US);

Ronald Charles Hawley, Glen Ridge, NJ (US);

Rama Kondru, Morris Plains, NJ (US);

Yingjie Lai, Cupertino, CA (US);

Yan Lou, Clifton, NJ (US);

Assignee:

Roche Palo Alto LLC, Palo Alto, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/14 (2006.01); C07D 413/04 (2006.01); A61K 31/5513 (2006.01); A61K 31/553 (2006.01); A61P 29/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

This application discloses 5-phenyl-1H-pyridin-2-one, 6-phenyl-2H-pyridazin-3-one, and 5-phenyl-1H-pyrazin-2-one derivatives according to generic Formulae I-II: wherein, variables Q, Q, R, X, Y, Y, Y, Y, Y, Y, m, and p are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions containing compounds of Formulae I-II and at least one carrier, diluent or excipient.


Find Patent Forward Citations

Loading…